Goldman Urology Clinic has recently introduced a next-generation extracorporeal shock wave lithotripsy system called “UROSTONE,” which incorporates advanced artificial intelligence (AI) technology.
The new device is equipped with Korea-patented technologies, including an AI respiratory trigger system and an AI auto-focusing function, and is considered to significantly improve the precision and efficiency of urinary stone treatment.
Conventional shock wave lithotripsy systems have limitations because the position of the stone can shift slightly as the patient breathes. When this happens, the shock wave may miss the exact target point, reducing the effectiveness of stone fragmentation. In contrast, UROSTONE features a respiration-linked targeting system that uses AI to analyze the patient’s breathing pattern in real time and track even subtle movements of the stone. The system automatically readjusts the shock wave to maintain accurate targeting of the stone’s center, improving fragmentation efficiency and reducing the overall treatment time.
In addition, the system is equipped with the only AI-based auto-focusing function in Korea that utilizes advanced image recognition technology. This function automatically analyzes and adjusts the position and focal point of the stone, maximizing procedural accuracy.
A representative from Goldman Urology Clinic explained that the AI technology simultaneously detects both the patient’s breathing and the movement of the stone, automatically optimizing the shock wave delivery. As a result, the treatment can be performed more precisely and safely. The clinic expects that the new system will shorten procedure time, reduce patient discomfort, and decrease the need for repeat treatments, ultimately improving patient satisfaction.